Clinical Trials
30 trials(NeoScorch HN)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
University of Texas Southwestern Medical Center
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
Merus B.V.
ORATOR2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT
Chang Gung Memorial Hospital
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
M.D. Anderson Cancer Center
UPFRONT-NECK
Insel Gruppe AG, University Hospital Bern
Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers
University of Kentucky
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
University of California, San Diego
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
University of Chicago
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
University of Kentucky
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
H. Lee Moffitt Cancer Center and Research Institute
Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome
Wake Forest University Health Sciences
INFIELD
University of Texas Southwestern Medical Center
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
SLICER
Peking University
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
University of Texas Southwestern Medical Center
Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Swiss Cancer Institute
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Amgen
Electrochemotherapy on Head and Neck Cancer
Rigshospitalet, Denmark
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
Radiation Therapy Oncology Group
Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
Radiation Therapy Oncology Group